Enzon Pharmaceuticals Inc (ENZN)
0.13
0.00 (0.00%)
USD |
OTCM |
May 23, 11:15
Enzon Pharmaceuticals Shareholders Equity (Quarterly): 3.294M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.294M |
December 31, 2023 | 3.505M |
September 30, 2023 | 2.515M |
June 30, 2023 | 2.725M |
March 31, 2023 | 3.073M |
December 31, 2022 | 3.407M |
September 30, 2022 | 2.756M |
June 30, 2022 | 3.302M |
March 31, 2022 | 4.046M |
December 31, 2021 | 4.868M |
September 30, 2021 | 5.608M |
June 30, 2021 | 6.34M |
March 31, 2021 | 6.865M |
December 31, 2020 | 7.36M |
September 30, 2020 | 5.17M |
June 30, 2020 | 5.577M |
March 31, 2020 | 5.813M |
December 31, 2019 | 6.055M |
September 30, 2019 | 6.317M |
June 30, 2019 | 11.95M |
March 31, 2019 | 11.97M |
December 31, 2018 | 14.99M |
September 30, 2018 | 8.111M |
June 30, 2018 | 8.631M |
March 31, 2018 | 8.832M |
Date | Value |
---|---|
December 31, 2017 | 9.144M |
September 30, 2017 | 8.682M |
June 30, 2017 | 15.16M |
March 31, 2017 | 10.98M |
December 31, 2016 | 10.33M |
September 30, 2016 | 21.58M |
June 30, 2016 | 20.64M |
March 31, 2016 | 19.61M |
December 31, 2015 | 18.09M |
September 30, 2015 | 16.65M |
June 30, 2015 | 18.46M |
March 31, 2015 | 36.77M |
December 31, 2014 | 29.60M |
September 30, 2014 | 28.22M |
June 30, 2014 | 20.64M |
March 31, 2014 | 13.77M |
December 31, 2013 | 5.255M |
September 30, 2013 | 19.78M |
June 30, 2013 | 14.05M |
March 31, 2013 | 79.46M |
December 31, 2012 | 77.47M |
September 30, 2012 | 179.72M |
June 30, 2012 | 191.52M |
March 31, 2012 | 197.15M |
December 31, 2011 | 197.18M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.515M
Minimum
Sep 2023
11.95M
Maximum
Jun 2019
5.027M
Average
5.019M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 4.826M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Electromed Inc | 42.54M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 46.83M |
Total Liabilities (Quarterly) | 43.54M |